Chemotherapy may be overused at the end of lifeBMJ 2001; 322 doi: https://doi.org/10.1136/bmj.322.7297.1267/a (Published 26 May 2001) Cite this as: BMJ 2001;322:1267
- Scott Gottlieb
- New York
Many patients with cancer receive chemotherapy at the end of life, even if their kind of cancer is known to be unresponsive to the drugs, according to a study reported at the recent annual meeting of the American Society of Clinical Oncologists held in San Francisco.
The finding “strongly suggests overuse of chemotherapy at the end of life,” lead author Dr Ezekiel Emanuel, chairman of the department of clinical bioethics at the US National Institutes of Health, told delegates. “Many are concerned with the quality of end of life care and specifically that patients …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial